New research published today in Nature Communications, describes how CRISPR-Cas9 gene editing can be used to create new nonribosomal peptide synthetase (NRPS) enzymes that deliver clinically important ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback